Annovis Bio Inc.

NYSE: ANVS · Real-Time Price · USD
2.73
0.01 (0.37%)
At close: Aug 15, 2025, 3:59 PM
2.72
-0.37%
After-hours: Aug 15, 2025, 05:59 PM EDT

Annovis Bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
10.55M 5.75M 28.38M 45.69M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
n/a 20.8K 11.24K 9.87K
Total Current Assets
13.93M 10.21M 36.02M 46M
Property-Plant & Equipment
n/a n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
n/a n/a n/a n/a
Total Assets
13.93M 10.21M 36.02M 46M
Account Payables
2.31M 1.29M 3.96M 688.07K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
1.21M 273.00 285.00 n/a
Total Current Liabilities
3.88M 4.28M 7.7M 1.51M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
737K 13.68M n/a n/a
Total Long-Term Liabilities
737K 13.68M 3.96M n/a
Total Liabilities
4.62M 17.96M 7.7M 1.51M
Total Debt
n/a n/a n/a n/a
Common Stock
1.41K 1.05K 816.00 810.00
Retained Earnings
-134.85M -110.26M -54.05M -28.73M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
9.31M -7.75M 28.32M 44.49M
Total Investments
10.54B n/a n/a n/a